BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 12210753)

  • 1. Systemically administered rhBMP-2 promotes MSC activity and reverses bone and cartilage loss in osteopenic mice.
    Turgeman G; Zilberman Y; Zhou S; Kelly P; Moutsatsos IK; Kharode YP; Borella LE; Bex FJ; Komm BS; Bodine PV; Gazit D
    J Cell Biochem; 2002; 86(3):461-74. PubMed ID: 12210753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited but heterogeneous osteogenic response of human bone marrow mesenchymal stem cells to bone morphogenetic protein-2 and serum.
    Mizuno D; Agata H; Furue H; Kimura A; Narita Y; Watanabe N; Ishii Y; Ueda M; Tojo A; Kagami H
    Growth Factors; 2010 Feb; 28(1):34-43. PubMed ID: 19835486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of recombinant human bone morphogenetic protein-2 on the osteogenic potential of rat mesenchymal stem cells after several passages.
    Ishikawa H; Kitoh H; Sugiura F; Ishiguro N
    Acta Orthop; 2007 Apr; 78(2):285-92. PubMed ID: 17464620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells.
    Kim DJ; Moon SH; Kim H; Kwon UH; Park MS; Han KJ; Hahn SB; Lee HM
    Spine (Phila Pa 1976); 2003 Dec; 28(24):2679-84. PubMed ID: 14673369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human bone morphogenetic protein-2 promotes the proliferation of mesenchymal stem cells in vivo and in vitro.
    Liu SB; Hu PZ; Hou Y; Li P; Cao W; Tian Q
    Chin Med J (Engl); 2009 Apr; 122(7):839-43. PubMed ID: 19493400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor-2 augments recombinant human bone morphogenetic protein-2-induced osteoinductive activity.
    Tanaka E; Ishino Y; Sasaki A; Hasegawa T; Watanabe M; Dalla-Bona DA; Yamano E; van Eijden TM; Tanne K
    Ann Biomed Eng; 2006 May; 34(5):717-25. PubMed ID: 16568346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of recombinant human BMP-2 on the repair of cricoid cartilage defects in young and adult rabbits: a comparative study.
    Tcacencu I; Carlsöö B; Stierna P
    Int J Pediatr Otorhinolaryngol; 2005 Sep; 69(9):1239-46. PubMed ID: 15888347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation.
    Liu HW; Chen CH; Tsai CL; Hsiue GH
    Bone; 2006 Oct; 39(4):825-36. PubMed ID: 16782421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous recombinant human BMP-2 has little initial effects on human osteoblastic cells cultured on collagen type I coated/noncoated hydroxyapatite ceramic granules.
    Turhani D; Weissenböck M; Stein E; Wanschitz F; Ewers R
    J Oral Maxillofac Surg; 2007 Mar; 65(3):485-93. PubMed ID: 17307597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant TGF-beta1 stimulates bone marrow osteoprogenitor cell activity and bone matrix synthesis in osteopenic, old male mice.
    Gazit D; Zilberman Y; Turgeman G; Zhou S; Kahn A
    J Cell Biochem; 1999 Jun; 73(3):379-89. PubMed ID: 10321837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoclast differentiation in ectopic bone formation induced by recombinant human bone morphogenetic protein 2 (rhBMP-2).
    Irie K; Alpaslan C; Takahashi K; Kondo Y; Izumi N; Sakakura Y; Tsuruga E; Nakajima T; Ejiri S; Ozawa H; Yajima T
    J Bone Miner Metab; 2003; 21(6):363-9. PubMed ID: 14586792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demineralized bone matrix supplied by bone banks for a carrier of recombinant human bone morphogenetic protein (rhBMP-2): a substitute for autogeneic bone grafts.
    Niederwanger M; Urist MR
    J Oral Implantol; 1996; 22(3-4):210-5. PubMed ID: 9524496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carrier dependent cell differentiation of bone morphogenetic protein-2 induced osteogenesis and chondrogenesis during the early implantation stage in rats.
    Takita H; Vehof JW; Jansen JA; Yamamoto M; Tabata Y; Tamura M; Kuboki Y
    J Biomed Mater Res A; 2004 Oct; 71(1):181-9. PubMed ID: 15368268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic osteoinduction and early degradation of recombinant human bone morphogenetic protein-2-loaded porous beta-tricalcium phosphate in mice.
    Liang G; Yang Y; Oh S; Ong JL; Zheng C; Ran J; Yin G; Zhou D
    Biomaterials; 2005 Jul; 26(20):4265-71. PubMed ID: 15683650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell-mediated gene therapy.
    Gazit D; Turgeman G; Kelley P; Wang E; Jalenak M; Zilberman Y; Moutsatsos I
    J Gene Med; 1999; 1(2):121-33. PubMed ID: 10738576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoinduction in human fat-derived stem cells by recombinant human bone morphogenetic protein-2 produced in Escherichia coli.
    Bessa PC; Pedro AJ; Klösch B; Nobre A; van Griensven M; Reis RL; Casal M
    Biotechnol Lett; 2008 Jan; 30(1):15-21. PubMed ID: 17673947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose- and time-dependent effects of recombinant human bone morphogenetic protein-2 on the osteogenic and adipogenic potentials of alveolar bone-derived stromal cells.
    Park JC; Kim JC; Kim BK; Cho KS; Im GI; Kim BS; Kim CS
    J Periodontal Res; 2012 Oct; 47(5):645-54. PubMed ID: 22471302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectopic bone formation in mice associated with a lactic acid/dioxanone/ethylene glycol copolymer-tricalcium phosphate composite with added recombinant human bone morphogenetic protein-2.
    Kato M; Namikawa T; Terai H; Hoshino M; Miyamoto S; Takaoka K
    Biomaterials; 2006 Jul; 27(21):3927-33. PubMed ID: 16564087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of growth and osteogenic differentiation of rabbit bone marrow stromal cells.
    Roostaeian J; Carlsen B; Simhaee D; Jarrahy R; Huang W; Ishida K; Rudkin GH; Yamaguchi DT; Miller TA
    J Surg Res; 2006 Jun; 133(2):76-83. PubMed ID: 16360178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of immobilized recombinant human bone morphogenetic protein-2/succinylated type I atelocollagen on cellular activity of ST2 cells.
    Tsujigiwa H; Nagatsuka H; Gunduz M; Rodriguez A; Rivera RS; Legeros RZ; Inoue M; Nagai N
    J Biomed Mater Res A; 2005 Oct; 75(1):210-5. PubMed ID: 16059889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.